BACKGROUND: Patients in the neonatal intensive care unit (NICU) are at high risk for healthcare-associated infections. Variability in reported infection rates among NICUs exists, possibly related to differences in prevention strategies. A better understanding of current prevention practices may help identify prevention gaps and areas for further research. METHODS: We surveyed infection control staff in NICUs reporting to the National Healthcare Safety Network (NHSN) to assess strategies used to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission and central line-associated bloodstream infections in NICUs. RESULTS: Staff from 162 of 342 NICUs responded (response rate, 47.3%). Most (92.3%) NICUs use central line insertion and maintenance bundles, but maintenance practices varied, including agents used for antisepsis and frequency of dressing changes. Forty-two percent reported routine screening for MRSA colonization upon admission for all patients. Chlorhexidine gluconate (CHG) use for central line care for at least 1 indication (central line insertion, dressing changes, or port/cap antisepsis) was reported in 82 NICUs (51.3%). Among sixty-five NICUs responding to questions on CHG use restrictions, 46.2% reported no restrictions. CONCLUSIONS: Our survey illustrated heterogeneity of CLABSI and MRSA prevention practices and underscores the need for further research to define optimal strategies and evidence-based prevention recommendations for neonates.
BACKGROUND:Patients in the neonatal intensive care unit (NICU) are at high risk for healthcare-associated infections. Variability in reported infection rates among NICUs exists, possibly related to differences in prevention strategies. A better understanding of current prevention practices may help identify prevention gaps and areas for further research. METHODS: We surveyed infection control staff in NICUs reporting to the National Healthcare Safety Network (NHSN) to assess strategies used to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission and central line-associated bloodstream infections in NICUs. RESULTS: Staff from 162 of 342 NICUs responded (response rate, 47.3%). Most (92.3%) NICUs use central line insertion and maintenance bundles, but maintenance practices varied, including agents used for antisepsis and frequency of dressing changes. Forty-two percent reported routine screening for MRSA colonization upon admission for all patients. Chlorhexidine gluconate (CHG) use for central line care for at least 1 indication (central line insertion, dressing changes, or port/cap antisepsis) was reported in 82 NICUs (51.3%). Among sixty-five NICUs responding to questions on CHG use restrictions, 46.2% reported no restrictions. CONCLUSIONS: Our survey illustrated heterogeneity of CLABSI and MRSA prevention practices and underscores the need for further research to define optimal strategies and evidence-based prevention recommendations for neonates.
Authors: Kristina A Bryant; Danielle M Zerr; W Charles Huskins; Aaron M Milstone Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: Marlene R Miller; Michael Griswold; J Mitchell Harris; Gayane Yenokyan; W Charles Huskins; Michele Moss; Tom B Rice; Debra Ridling; Deborah Campbell; Peter Margolis; Stephen Muething; Richard J Brilli Journal: Pediatrics Date: 2010-01-11 Impact factor: 7.124
Authors: D D Wirtschafter; J Pettit; P Kurtin; M Dalsey; K Chance; H W Morrow; M Seid; T L Byczkowski; T P Huber; J M Milstein; S M Bowles; S Fichera; S Kloman Journal: J Perinatol Date: 2009-11-26 Impact factor: 2.521
Authors: Joseph Schulman; Rachel Stricof; Timothy P Stevens; Michael Horgan; Kathleen Gase; Ian R Holzman; Robert I Koppel; Suhas Nafday; Kathleen Gibbs; Robert Angert; Aryeh Simmonds; Susan A Furdon; Lisa Saiman Journal: Pediatrics Date: 2011-02-21 Impact factor: 7.124
Authors: David D Wirtschafter; Richard J Powers; Janet S Pettit; Henry C Lee; W John Boscardin; Mohammad Ahmad Subeh; Jeffrey B Gould Journal: Pediatrics Date: 2011-02-21 Impact factor: 7.124
Authors: Julia Johnson; Rebecca Bracken; Pranita D Tamma; Susan W Aucott; Cynthia Bearer; Aaron M Milstone Journal: Infect Control Hosp Epidemiol Date: 2016-06-20 Impact factor: 3.254
Authors: Taj Azarian; Nizar F Maraqa; Robert L Cook; Judith A Johnson; Christine Bailey; Sarah Wheeler; David Nolan; Mobeen H Rathore; J Glenn Morris; Marco Salemi Journal: PLoS One Date: 2016-10-12 Impact factor: 3.240